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A position statement is an ofﬁcial point
of view or belief of the ADA. Position
statements are issued on scientiﬁc or
medical issues related to diabetes. They
may be authored or unauthored and are
published in ADA journals and other
scientiﬁc/medical publications as ap-
propriate. Position statements must be
reviewed and approved by the Profes-
sional Practice Committee and, subse-
quently, by the Executive Committee of
the Board of Directors. ADA position
statements are typically based on a tech-
nical review or other review of published
literature.Theyarereviewedonanannual
basis and updated as needed. In addition
to those published in this supplement,
listed below are recent position state-
ments.
Aspirin for Primary Prevention of
Cardiovascular Events in People
With Diabetes: A Position Statement
of the American Diabetes
Association, a Scientiﬁc Statement
of the American Heart Association,
and an Expert Consensus Document
of the American College of
Cardiology Foundation
Michael Pignone, Mark J. Alberts, John A.
Colwell, Mary Cushman, Silvio E. Inzuc-
chi, Debabrata Mukherjee, Robert S.
Rosenson, Craig D. Williams, Peter W.
Wilson, and M. Sue Kirkman
Diabetes Care 33:1395–1402, 2010
Exercise and Type 2 Diabetes: The
American College of Sports Medicine
and the American Diabetes
Association: Joint Position
Statement
SheriR.Colberg,RonaldJ.Sigal,BoFern-
hall, Judith G. Regensteiner, Bryan J.
Blissmer, Richard R. Rubin, Lisa Chasan-
Taber, Ann L. Albright, and Barry Braun
Diabetes Care 33:e147–e167, 2010
Clinical Care Guidelines for Cystic
Fibrosis–Related Diabetes: A
Position Statement of the American
Diabetes Association and a Clinical
Practice Guideline of the Cystic
Fibrosis Foundation, Endorsed by
the Pediatric Endocrine Society
Antoinette Moran, Carol Brunzell, Rich-
ard C. Cohen, Marcia Katz, Bruce C. Mar-
shall, Gary Onady, Karen A. Robinson,
Kathryn A. Sabadosa, Arlene Stecenko,
and Bonnie Slovis, the CFRD Guidelines
Committee
Diabetes Care 33:2697–2708, 2010
Intensive Glycemic Control and the
Prevention of Cardiovascular Events:
Implications of the ACCORD,
ADVANCE, and VA Diabetes Trials:
A Position Statement of the
American Diabetes Association and
a Scientiﬁc Statement of the
American College of Cardiology
Foundation and the American Heart
Association
Jay S. Skyler, Richard Bergenstal, Robert
O. Bonow, John Buse, Prakash Deed-
wania, Edwin A.M. Gale, Barbara V.
Howard, M. Sue Kirkman, Mikhail Kosi-
borod, Peter Reaven, and Robert S. Sher-
win
Diabetes Care 32:187–192, 2009
Nutrition Recommendations and
Interventions for Diabetes: A
Position Statement of the American
Diabetes Association
American Diabetes Association
Diabetes Care 31 (Suppl. 1):S61–S78, 2008
Generic Drugs: A Position Statement
of the American Diabetes
Association
American Diabetes Association
Diabetes Care 30:173, 2007
Pancreas and Islet Transplantation
in Type 1 Diabetes: A Position of the
American Diabetes Association
American Diabetes Association
Diabetes Care 29:935, 2006
The Metabolic Syndrome: Time for a
Critical Appraisal: Joint Statement
From the American Diabetes
Association and the European
Association for the Study of
Diabetes
Richard Kahn, John Buse, Ele Ferrannini,
and Michael Stern
Diabetes Care 28:2289, 2005
Diabetic Neuropathies: A Statement
by the American Diabetes
Association
Andrew J.M. Boulton, Arthur I. Vinik, Jo-
sephC.Arezzo,VeraBril,EvaL.Feldman,
Roy Freeman, Rayaz A. Malik, Raelene E.
Maser, Jay M. Sosenko, and Dan Ziegler
Diabetes Care 28:956, 2005
Care of Children and Adolescents
With Type 1 Diabetes: A Statement
of the American Diabetes
Association
Janet Silverstein, Georgeanna Klingen-
smith, Kenneth Copeland, Leslie Plot-
nick,FrancineKaufman,LoriLaffel,Larry
Deeb, Margaret Grey, Barbara Anderson,
Lea Ann Holzmeister, and Nathaniel
Clark
Diabetes Care 28:186, 2005
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